MSRV Env induced in both healthy donors and MS patients the in vitro polyclonal activation of Vβ16 T-lymphocytes [126] and the subsequent increase of multiple pro-inflammatory cytokines [126,127]. Here, ERVW-1 is linked to myeloid sarcoma.